本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cognition Therapeutics, Inc

1.01
+0.02722.77%
盤後1.020.0100+0.99%17:45 EDT
成交量:22.90萬
成交額:23.04萬
市值:9,604.47萬
市盈率:-5.22
高:1.03
開:0.9872
低:0.9703
收:0.9828
52周最高:2.38
52周最低:0.5501
股本:9,509.37萬
流通股本:8,542.20萬
量比:0.70
換手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):-0.1936
每股收益(LYR):-0.3228
淨資產收益率:-83.76%
總資產收益率:-78.18%
市淨率:2.91
市盈率(LYR):-3.13

資料載入中...

2022/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/10

重要事件披露

8-K - Current report
2021/11/18

重要事件披露

8-K - Current report
2021/11/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/11/03

重要事件披露

8-K - Current report
2021/11/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/14

重要事件披露

8-K - Current report
2021/10/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/20

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence